TRPM8 polymorphisms are associated with slower colonic transit and increased risk of IBS-C and IBS-MTRPM8 agonists (L-menthol) decrease IBS pain symptoms and reduce the release of inflammatory cytokines IL-1β, IL-6, and TNF-α. Here, TNF is linked to irritable bowel syndrome.